Bill Text: IA SSB1017 | 2013-2014 | 85th General Assembly | Introduced
Bill Title: A study bill for an act relating to controlled substances by making changes to the list of substances classified as controlled substances, allowing the exchange of information among prescription databases and monitoring programs, and making penalties applicable.
Spectrum: Unknown
Status: (N/A - Dead) 0000-00-00 - Human Resources: Wilhelm Chair,Quirmbach, and Whitver. [SSB1017 Detail]
Download: Iowa-2013-SSB1017-Introduced.html
Senate
Study
Bill
1017
-
Introduced
SENATE/HOUSE
FILE
_____
BY
(PROPOSED
DEPARTMENT
OF
PUBLIC
HEALTH/BOARD
OF
PHARMACY
BILL)
A
BILL
FOR
An
Act
relating
to
controlled
substances
by
making
changes
to
1
the
list
of
substances
classified
as
controlled
substances,
2
allowing
the
exchange
of
information
among
prescription
3
databases
and
monitoring
programs,
and
making
penalties
4
applicable.
5
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
6
TLSB
1154DP
(3)
85
jm/nh
S.F.
_____
H.F.
_____
Section
1.
Section
124.208,
subsection
6,
Code
2013,
is
1
amended
by
adding
the
following
new
paragraphs:
2
NEW
PARAGRAPH
.
bk.
Methasterone
3
(2[alpha],17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3-one).
4
NEW
PARAGRAPH
.
bl.
Prostanozol
5
(17[beta]-hydroxy-5[alpha]-androstano[3,2-c]pyrazole).
6
Sec.
2.
Section
124.553,
subsection
1,
Code
2013,
is
amended
7
by
adding
the
following
new
paragraph:
8
NEW
PARAGRAPH
.
d.
A
prescription
database
or
monitoring
9
program
in
another
jurisdiction
pursuant
to
subsection
8.
10
Sec.
3.
Section
124.553,
Code
2013,
is
amended
by
adding
the
11
following
new
subsection:
12
NEW
SUBSECTION
.
8.
The
board
may
enter
into
agreements
for
13
the
mutual
exchange
of
information
among
prescription
database
14
or
monitoring
programs
in
other
jurisdictions.
Any
agreement
15
entered
into
pursuant
to
this
subsection
shall
specify
that
all
16
the
information
exchanged
shall
be
used
and
disseminated
in
17
accordance
with
the
laws
of
this
state.
18
EXPLANATION
19
This
bill
adds
substances
to
the
list
of
substances
20
classified
as
controlled
substances
and
relates
to
the
exchange
21
of
information
among
prescription
databases
and
monitoring
22
programs.
23
The
bill
classifies
the
anabolic
steroids
methasterone
24
and
prostanozol
as
schedule
III
controlled
substances.
The
25
criteria
used
to
classify
a
substance
as
a
schedule
III
26
controlled
substance
is
established
in
Code
section
124.207.
27
It
is
a
class
“C”
felony
pursuant
to
Code
section
28
124.401(1)(c)(8)
for
any
unauthorized
person
to
violate
a
29
provision
of
Code
section
124.401
involving
a
controlled
30
substance
placed
on
schedule
I,
II,
or
III
pursuant
to
the
31
bill.
A
class
“C”
felony
for
this
particular
offense
is
32
punishable
by
confinement
for
no
more
than
10
years
and
a
fine
33
of
at
least
$1,000
but
not
more
than
$50,000.
34
If
a
person
possesses
a
controlled
substance
in
violation
of
35
-1-
LSB
1154DP
(3)
85
jm/nh
1/
2
S.F.
_____
H.F.
_____
Code
section
124.401(5)
as
a
first
offense,
the
person
commits
1
a
serious
misdemeanor.
A
serious
misdemeanor
is
punishable
2
by
confinement
for
no
more
than
one
year
and
a
fine
of
at
3
least
$315
but
not
more
than
$1,875.
A
second
offense
is
an
4
aggravated
misdemeanor
punishable
by
confinement
for
no
more
5
than
two
years
and
a
fine
of
at
least
$625
but
not
more
than
6
$6,250.
A
subsequent
offense
is
a
class
“D”
felony
punishable
7
by
confinement
for
no
more
than
five
years
and
a
fine
of
at
8
least
$750
but
not
more
than
$7,500.
9
The
bill
also
authorizes
the
board
of
pharmacy
to
enter
10
into
agreements
with
other
jurisdictions
in
order
to
exchange
11
information
from
the
Iowa
prescription
monitoring
program
with
12
similar
programs
in
other
jurisdictions.
13
The
bill
requires
that
any
agreement
entered
into
shall
14
specify
that
all
the
information
exchanged
shall
be
used
and
15
disseminated
in
accordance
with
the
laws
of
this
state.
16
The
Iowa
prescription
monitoring
program
is
used
by
17
prescribing
practitioners
and
pharmacists
on
a
need-to-know
18
basis
for
facilitating
early
identification
of
patients
who
19
may
be
at
risk
for
addiction,
or
who
may
be
using,
abusing,
20
or
diverting
drugs
for
unlawful
or
otherwise
unauthorized
21
purposes.
22
-2-
LSB
1154DP
(3)
85
jm/nh
2/
2
